Steven Sell - 14 Apr 2022 Form 4 Insider Report for agilon health, inc. (AGL)

Role
CEO & President, Director
Signature
/s/ Lyn Amor Macaraeg, as Attorney-in-Fact
Issuer symbol
AGL
Transactions as of
14 Apr 2022
Net transactions value
$0
Form type
4
Filing time
20 Apr 2022, 16:57:59 UTC
Previous filing
15 Sep 2021
Next filing
22 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGL Common Stock Award $0 +48,765 $0.000000 48,765 14 Apr 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGL Options (Rights to Buy) Award $0 +160,486 $0.000000 160,486 14 Apr 2022 Common Stock 160,486 $23.07 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units that vest in four equal installments on each anniversary of April 14, 2022, subject to continued employment.
F2 Includes restricted stock units.
F3 Options that vest in four equal installments on each anniversary of April 14, 2022, subject to continued employment.